Related Experiment Videos
[Liver hemosiderosis in chronic hepatitis]
O A Smirnov1, N M Anichkov, V G Radchenko
1I.M. Mechnikov Saint-Petersburg State Medical Academy, 195067, Saint-Petersburg.
Arkhiv Patologii
|April 3, 2003
Summary
Liver hemosiderosis, a marker of iron overload, is common in chronic hepatitis B, C, and alcoholic liver disease. Its presence is linked to more severe disease and reduced treatment effectiveness.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Context:
- Liver hemosiderosis (LH) is a condition indicating organ iron overload.
- Chronic hepatitis (CH) encompasses viral (B, C) and alcoholic (AL) etiologies.
- Understanding LH prevalence and associations is crucial for patient management.
Purpose:
- To investigate the incidence and clinical associations of liver hemosiderosis in patients with chronic hepatitis.
- To evaluate the impact of LH on disease severity and treatment efficacy.
Summary:
- Liver hemosiderosis was present in 39.4% of patients with chronic hepatitis (B, C, or AL).
- Incidence rates were 33.3% in CH B, 49.3% in CH C, and 48.7% in AL.
- LH correlated with longer disease duration, higher activity, and advanced hepatic cirrhosis.
Impact:
- Liver hemosiderosis is associated with more severe chronic hepatitis and alcoholic liver disease.
- Reaferon therapy showed reduced efficacy in hepatitis B and C patients with LH.
- These findings highlight LH as secondary hemosiderosis, impacting therapeutic outcomes.